In Vascular Biology & Thrombosis Research
The Bernd R. Binder Publication Prize was established in Memory of the founder of Technoclone Prof. Dr. Bernd R. Binder (1945-2010) to promote young scientists who have shown an outstanding contribution to the field of Vascular Biology and Thrombosis Research.
This prize underlines Technoclone's tradition in fostering and supporting innovative research in academia an outstanding contribution to the field of Vascular Biology and Thrombosis Research.
Bernd R. Binder Publication Price 2019
The deadline for the application for the Bernd R. Binder Publication Price 2019 is
March 31st, 2020. The awardee will present the paper at the Bernd R. Binder Memorial Lecture at the Joint Meeting on Vascular Biology, Inflammation and Thrombosis on May 14th 2020 in Vienna, Austria.
Apply now for the Bernd R. Binder Publication Price 2019 under https://inthro.meduniwien.ac.at/joint-meeting/bernd-r-binder-prize/ or directly via the the form https://inthro.meduniwien.ac.at/fileadmin/inthro/form/Application_form_B...
We look forward receiving your application!
About the BRB Publication Price
One award of € 2,500.- to the first author of an excellent original article in the areas of Vascular Biology and Thrombosis Research published in an international peer-reviewed journal.
Applicants are first author of a publication from an independent research institution (university, public research institute, etc.) in the area of Vascular Biology and/or Thrombosis Research.
The paper must be a journal article published (in print or online) in an international peer-reviewed journal in the corresponding year.
The prize will be awarded following the recommendation of a selected prize award committee.
The awardee has to agree to present the paper at the Bernd R. Binder Memorial Lecture.
For any further questions please contact email@example.com
Selective EGF-Receptor Inhibition in CD4þ T Cells Induces Anergy and Limits Atherosclerosis
Host DNases prevent vascular
Dr. Emiel van der Vorst
High-Density Lipoproteins Exert Pro-
Dr. Katrin F. Nickel
The polyphosphate-factor XII pathway
Dr. Andrew Sage
MHC Class II-Restricted Antigen
Dipl. Bio Martin Schmitt
Endothelial JAM-A guides monocytes into